 |
|
|
Mar '07 |
Jun '07 |
Sep '07 |
Dec '07 |
Mar '08 |
|
| Sales Turnover |
33.70 |
35.19 |
41.35 |
40.40 |
33.12 |
| Other Income |
0.08 |
-- |
-- |
-- |
-- |
| Total Income |
33.78 |
35.19 |
41.35 |
40.40 |
33.12 |
| Total Expenses |
30.70 |
31.78 |
36.82 |
38.15 |
30.18 |
| Operating Profit |
3.00 |
3.41 |
4.53 |
2.25 |
2.94 |
| Profit On Sale Of Assets |
-- |
-- |
-- |
-- |
-- |
| Profit On Sale Of Investments |
-- |
-- |
-- |
-- |
-- |
| Gain/Loss On Foreign Exchange |
-- |
-- |
-- |
-- |
-- |
| VRS Adjustment |
-- |
-- |
-- |
-- |
-- |
| Other Extraordinary Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Total Extraordinary Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Tax On Extraordinary Items |
-- |
-- |
-- |
-- |
-- |
| Net Extra Ordinary Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Gross Profit |
3.08 |
3.41 |
4.53 |
2.25 |
2.94 |
| Interest |
1.64 |
1.85 |
1.56 |
1.33 |
1.61 |
| PBDT |
1.45 |
1.56 |
2.97 |
0.92 |
1.33 |
| Depreciation |
0.40 |
0.39 |
0.41 |
0.41 |
0.42 |
| Depreciation On Revaluation Of Assets |
-- |
-- |
-- |
-- |
-- |
| PBT |
1.05 |
1.17 |
2.56 |
0.51 |
0.91 |
| Tax |
-0.02 |
0.42 |
0.85 |
0.29 |
0.30 |
| Net Profit |
1.07 |
0.75 |
1.71 |
0.22 |
0.61 |
| Prior Years Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Depreciation for Previous Years Written Back/ Provided |
-- |
-- |
-- |
-- |
-- |
| Dividend |
-- |
-- |
-- |
-- |
-- |
| Dividend Tax |
-- |
-- |
-- |
-- |
-- |
| Dividend (%) |
-- |
-- |
-- |
-- |
-- |
| Earnings Per Share |
0.41 |
0.28 |
0.65 |
0.08 |
0.23 |
| Book Value |
-- |
-- |
-- |
-- |
-- |
| Equity |
13.10 |
13.10 |
13.10 |
13.10 |
13.10 |
| Reserves |
-- |
-- |
-- |
-- |
-- |
| Face Value |
5.00 |
5.00 |
5.00 |
5.00 |
5.00 |
|
|
|
|
|
| BSE: 507789 |
NSE: JAGSNPHARM |
Reuters: JGSN.BO JGSN.NS |
|
|
| Source : Asian CERC |
|
Offline
